HF1485

Coverage of over-the-counter contraceptive drugs, devices, and products by insurers and medical assistance required; and reports required.
Legislative Session 94 (2025-2026)

Related bill: SF1752

AI Generated Summary

Purpose

  • This bill would require health insurers and Minnesota Medical Assistance (MA) to cover over-the-counter (OTC) contraceptives and prescription contraceptives. It also includes a requirement for certain reporting and makes targeted amendments to Minnesota statutes related to health insurance coverage for contraception. The aim is to support prevention of unintended pregnancies by expanding access to contraceptives.

Main provisions

  • Coverage requirement for OTC contraceptives

    • Insurers and MA would be required to cover OTC contraceptives that are FDA-approved to prevent unintended pregnancy and do not require a prescription.
  • Coverage requirement for prescription contraceptives

    • Insurers and MA would be required to cover FDA-approved prescription contraceptives.
  • Definitions related to contraception

    • Contraceptive method: a drug, device, or other product approved by the FDA to prevent unintended pregnancy (whether OTC or prescription).
    • Contraceptive service: includes consultation, examination, procedures, and medical services connected to preventing unintended pregnancy. This includes patient education, counseling on contraceptives, follow-up services, management of side effects, and device insertion or removal. It excludes vasectomies but includes voluntary sterilization procedures.
    • Medical necessity: factors such as severity of side effects, differences in permanence and reversibility of methods, and the ability to adhere to use instructions, as determined by the attending provider.
    • OTC contraceptive: an FDA-approved contraceptive that does not require a prescription.
    • Prescription contraceptive: an FDA-approved contraceptive that requires a prescription.
  • Additional terminology and standards

    • Therapeutic equivalent version: a drug, device, or product that can be expected to have the same clinical effect and safety as the reference product when used as labeled. It must meet criteria such as identical active ingredient amounts, same dosage form and route, bioequivalence (or an acceptable alternative standard if not), proper labeling, and compliance with current manufacturing practices.
    • Pharmacy: defined as in existing Minnesota law.
    • Current manufacturing practice: adherence to the manufacturing standards in effect at the time.
  • Legislative amendments and reporting

    • The bill would amend Minnesota Statutes to incorporate these definitions and coverage requirements (specifically sections 62Q.522 and 256B.0625).
    • It also requires reporting related to the implemented coverage provisions (details are not specified in the text provided).
  • Note on contraceptive services vs. sterilization

    • Contraceptive services cover a wide range of counseling and medical care related to contraception but exclude vasectomies. Voluntary sterilization procedures are described as included in the scope of contraceptive services.

How this changes current law

  • Expands statutory requirements to cover OTC contraceptives in addition to prescription contraceptives, which broadens access for individuals who use OTC products.
  • Introduces explicit definitions for key terms (contraceptive method/service, medical necessity, OTC vs prescription contraceptives) to guide coverage decisions.
  • Aligns coverage criteria with medical standards related to effectiveness, safety, and labeling (therapeutic equivalence and bioequivalence concepts).
  • Adds a reporting requirement tied to these coverage provisions.
  • Clarifies which activities are considered part of contraceptive services (education, counseling, follow-up, device management) and confirms vasectomies are not included in the contraceptive service category, while certain sterilization procedures are.

Significant changes to existing law (highlights)

  • Mandated coverage for OTC contraceptives by private insurers and MA.
  • Expanded coverage to include prescription contraceptives.
  • New or clarified definitions that impact how contraceptive methods and services are understood and reimbursed.
  • Introduction of medical-necessity considerations for contraceptive care.
  • Incorporation of standards for therapeutic equivalence and bioequivalence in coverage decisions.
  • Requirement for reporting related to these coverage provisions.

Relevant Terms - FDA - over-the-counter contraceptive (OTC contraceptive) - prescription contraceptive - contraceptive method - contraceptive service - medical necessity - voluntary sterilization procedures - vasectomy (excluded from contraceptive service) - therapeutic equivalent version - bioequivalence - current manufacturing practice - pharmacy - Minnesota Statutes 62Q.522, 256B.0625

Bill text versions

Showing the most recent version. There are  2  total versions. You must be logged in  to view additional bill text versions.

Actions

DateChamberWhereTypeNameCommittee Name
February 24, 2025HouseActionIntroduction and first reading, referred toCommerce Finance and Policy
February 26, 2025HouseActionAuthors added
March 05, 2025HouseActionAuthor added
March 12, 2025HouseActionAuthor added
March 17, 2025HouseActionAuthor added
Showing the 5  most recent stages. This bill has 5  stages in total. Log in to view all stages

Citations

You must be logged in  to view citations.

Progress through the legislative process

17%
In Committee

Sponsors

You must be logged in  to view sponsors.

Loading…